Clinical Trial Update: A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density [Phase 3]

View source ↗

Summary

Phase 3 randomized, open-label trial comparing immunogenicity and safety of denosumab delivered via pre-filled syringe versus vial in adults with low bone miner…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Low Bone Mineral Density, Osteopenia | Phase 3 | Status: COMPLETED | Results posted: 2013-10-31